https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Hormel Foods Corporation (NYSE: HRL) resulting from allegations that Hormel may have issued materially misleading business information to the investing public. So What: If you purchased Hormel securities you may be entitled to […]

Chicago, Nov. 10, 2025 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes only and does not constitute financial, investment, or gambling advice. Online wagering involves risk. Please gamble responsibly and only with funds you can afford to lose. If you register or make a purchase through links in this article, a commission may

Sportsbook Promos for US Players: BetUS' Standout New Customer Bonus BetUS Launches a 225% Welcome Bonus Worth Up to $3,625, Giving U.S. Players a Stronger Start in 2025's Competitive Sports Betting Marke GlobeNewswire November 11, 2025 Chicago, Nov. 10, 2025 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes only and does not constitute

Edelson Lechtzin LLPis investigating potential violations of the federal securities laws involving Alvotech (“Alvotech” or “the Company”) (NASDAQ: ALVO), resulting from allegations of providing potentially misleading business information to the investing public. https://mma.prnewswire.com/media/2457789/logo2_Logo.jpg If you have non-public information that could assist in the Alvotech Investigation or if you are an Alvotech investor who suffered a

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Tvardi Therapeutics, Inc. ("Tvardi Therapeutics, Inc.") (NASDAQ:TVRD) concerning possible violations of federal securities laws. On October 13, 2025, Tvardi reported data from its Phase 2 REVERT study testing its STAT3 inhibitor drug,

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alvotech ("Alvotech") (NASDAQ:ALVO) concerning possible violations of federal securities laws. On November 2, 2025, Alvotech published a press release notifying investors that the Company received a Complete Response Letter (CRL) from the

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / If you suffered a loss on your V.F. Corporation (NYSE:VFC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/v-f-corporation-lawsuit-submission-form?prid=176596&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

https://mma.prnewswire.com/media/2468496/DOMA_PERPETUAL___Logo.jpg DOMA Controls 6.8% of Pacira Common Stock DOMA Perpetual Capital Management LLC, a significant stockholder of Pacira BioSciences, Inc. (NASDAQ: PCRX) (“Pacira”), today sent a letter to the Board of Directors of Pacira (the “Board”) urging the Board to hire bankers and conduct a full sale process of the company. The letter can be

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alvotech ("Alvotech") (NASDAQ:ALVO) concerning possible violations of federal securities laws. On November 2, 2025, Alvotech published a press release notifying investors that the Company received a Complete Response Letter (CRL) from the

https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers and acquirers ofSynopsys, Inc. (NASDAQ: SNPS) securities between December 4, 2024 and September 9, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish